chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fever; The initial case was missing the following minimum criteria: no adverse event. Upon receipt of follow-up information on 12Jan2021, this case now contains all required information to be considered valid.  This is a spontaneous report from a Pfizer-sponsored program, from a contactable physician (patient). A male patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route single dose for COVID-19 immunization on 02Jan2020. Medical history and concomitant medication were not reported. The patient received his first dose of BNT162B2 and experienced side effects afterwards. He started coming down with a fever took paracetamol (TYLENOL) to help with the fever (from Jan2021). Action taken for BNT162B2 was not applicable. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
Information has been received from a Nurse Practitioner concerning a 12 month old male who on 05, Feb 2007 was vaccinated SC with a first dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck upgrade process) (lot# 656447/11547F). On 13, Feb 2007 the patient experienced varicella / measles like rash at injection site after receiving the measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck upgrade process) vaccination. The rash, which was less than 50 lesions, was localized at the injection site. The  patient sought unspecified medical attention and was given diphenhydramine hydrochloride (BENADRYL) when the reaction presented. As of 15, Feb 2007 the patient was recovering. Additional information has been requested.
Patient states he has noted nose bleeds lasting 45 minutes and more easy bleeding from cuts. NO bruising or gum bleeding or petichiae  normal cbc
No issues until today, day 7.  Injection spot itching swellon a little and firm
Giant Cell Arteritis. Emergency Hospital Admission 9/16/2021, discharge after 5 days. Now under outpatient care, long term prednisone therapy.
technically not an adverse event, but an administration error - some of the vaccine leaked out onto the patient's arm upon administration
A health professional form was received on 02/28/2002 concerning a 75 year old male pt who experienced exacerbation of chronic obstructive pulmonary disease, which was considered medically significant 4 days after receiving a flvirin injection on 12/01/1998. The pt experienced exacerbation of chronic obstructive pulmonary disease on 12/05/1998 after receiving a fluvirin vaccine on 12/01/1998. The reporter assessed the causality as possibly related. No more information has been provided.
pt scream while lying in crib; face turning gray; face became more ashen; pt wanted to cry but was only able to grunt; stopped breathing;
Nausea. Stomach cramps. Fatigue. Muscle cramps in legs. Sore throat.
A report had been received from a Health Professional concerning an 11 years old, male patient. The relevant history and concomitant drugs of the patient were not reported. The patient had received nasal FLUMIST QUADRIVALENT of batch number BH2124 on 16-Sep-2013. The patient also received Tdap and MCV4 vaccines on that day. The nurse reported that the patient had right ear pain on 01-Oct-2013. The patient was diagnosed with right ear infection on 01-Oct-2013. The patient was started on CIPRODEX drops - four drops to right ear two times a day. The patient started to experience a symptom of Bell's palsy (right sided facial drooping) on 07-Oct-2013. Patient was seen in office on 08-Oct-2013. Doctor started him on ZITHROMAX 250 mg-two tablet, the first day, then one tablet for four days, Prednisone 20 mg tablet two tablet for seven days, one and half tablet for two days, then one tablet for two days then half tablet for two days and then one fourth tablet for two days. At the time of reporting, the event of patient's right sided droop had not improved. The outcome of the event of right ear infection was unknown. The reporter considered the events of right ear infection and right sided facial droop to be non-serious. Summary of follow-up information received by AstraZeneca/MedImmune on 09-Oct-2013 from health professional: Event verbatim and coding for event of right sided facial droop/Bell's palsy was updated. Reporter's type patient was added. Reporter's and patient's details were updated. Concomitant drugs were added. Narrative was amended. Corrected report 20-Oct-2013: Manufacturer for suspect vaccine was added.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "sinus allergy" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Dilaudid, reaction(s): "known allergies: dilaudid". The following information was reported: COVID-19 (medically significant) with onset Jun2022, outcome "not recovered", DRUG INEFFECTIVE (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jun2022) Positive, notes: I was positive with Covid-19 and I took the Paxlovid after the 4th day. The patient also reported that she was positive with Covid-19 and  took the Paxlovid after the 4th day  she still feel I have Covid and this time the symptoms was worse than the first one. She went to the Urgent Care and ER due to chest pain and they found T wave abnormality on my result.Therapeutic measures were taken as a result of drug ineffective, covid-19. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pale, motionless, no awakening normally, hyporesponsive rxn 13MAR96;
This spontaneous report was received from a registered nurse, referring to multiple unspecified patients of unknown age and gender. Information regarding the patients' medical history, concurrent conditions and concomitant medication were not reported. On unspecified dates, patients were administered doses of improperly stored PNEUMOVAX 23 (lot # and expiration date were not reported). It was reported that the vaccine was exposed for 270 hours at 9 Celsius degrees. No adverse effects were reported. It was reported that all the vaccines were back in range. The data logger was reported as yes. This is one of the several reports received from the same reporter. Additional information has been requested.
15 year old daughter developed, numb , tingling, weakness then full ? drop foot? on right leg . Dizzy, falling , for months .  Low blood pressure, Drop foot for 7 weeks until they have her Prednisone. Now she has numbness, low blood pressure, tingling, pain behind knee, peripheral neuropathy. Slowing resolving . Tired, dizzy , weak , low blood pressure still ongoing. She has been hospitalized, fainting, treated by EMT , ambulance for vasovegular fainting out of the blue. Blood tests , coming back with irregularities.
This spontaneous report was received from a registered nurse refers to an unspecified two patients of unknown age and gender. Medical history, concurrent conditions and concomitant medications were not reported. On an unknown dates, patients were vaccinated with two doses of improperly stored (temperature was 56 F for 2 hours, because of data logger) PNEUMOVAX 23, lot # L017265, expiry date 10-FEB-2017, (route of administration not reported). Previous temperature excursion was 68.5F for 11 hours 45 minutes. No adverse effects reported. The outcome of the events was unknown. No product quality complaint (PQC) was reported. Additional information has been requested.
Shortness of breath, gasping episodes times 6 that evening when she was lying down trying to sleep. She states that she did not go in to be seen in the ER.  She "walked it off" and reports symptoms resolved in the morning.  She estimated symptoms lasted 6 hours.
Patient was given vaccine and waited her required 15 min at facility to be monitored.  Aft this point she left, but reported that she immediately felt difficulty with breathing.  She explains that her throat and tongue started to swell so she drove directly to the closest emergency room where she was treated with Benadryl and steroids.  After a couple of hours of observation she was sent home without further issue.  She was given instructions to use Benadryl prior to her second vaccine and given an Epi pen to have just in case.  After discussion, this writer also recommended she follow up with her PCP to discuss having the vaccine in clinic vs at our facility.
Information has been received from a physician concerning an 8 year old white female who was vaccinated with varicella virus vaccine live. Subsequently the pt was diagnosed with chickenpox breakthrough. The pt had less than fifty lesions and only two crusted. The duration was reported as two days and the pt had a fever for one day. There was no product quality complaint involved. Follow up information indicated that on 11Jun04 at 10:30AM the pt developed a very slight case of chickenpox. Additional information has been requested.
Chills and low grade fever present upon waking in the morning. Slept most of the day. No breakfast. Reduced appetite was noted at lunch and throughout the rest of the day. Stomach cramps appeared following  a lunch of chicken noodle soup. Symptoms were not noticed the following day.
pt has had excessive screaming for 4 hrs straight; pt given vax 1145AM;
Patient came back on 10/18/17 and informed us that she fell sick with a fever of 101 degrees a day after getting the shot. She complained of body aches, chills, panic attacks, mental delusion, exhaustion, near suicidal, feeling hopeless and like she was drowning. She complained that this was a relapse since she has Bipolar and had not had these symptoms in years.
Pt developed arm/shoulder pain the next day then he started getting severe pain on his both wrist in about a week later and still having the severe pain till now. He is going to see his Dr in 2 days and will come back to get his 2nd dose if Dr recommends it.
Pt recv vax on 10/21/98; on 10/24/98 pt exp swollen lymph glands, swollen glands across clavicles w/ neck & thyroid discomfort, lump in throat; tx=Ibuprofen
Raised 2-2mm erythematous papules, various stages of development, some  central lesions, some scabbed over.
Pt with persistent LUE pain after getting her second dose of Pfizer COVID vaccine. Reports she had the 2nd dose on 3/23/21. 2 days later, she developed LUE pain. Worse in the front of her shoulder and under her armpit. Taking Ibuprofen/Tylenol with relief but if she isn't taking any, there is pain. Pain is worse with movement. Describes pain as aching/burning. Some weakness in LUE. Pt is R handed.
It was reported post vaccine pt developed a large area of redness under his L arm the size of an orange that was warm to touch.
12/26/21: Patient presents to ED on 12/26 c chief complaint of COVID positive and worsening shortness of breath.  Patient symptoms started 8 days prior to arrival.  Symptoms include cough/shortness of breath/dyspnea on exertion.  Upon presentation to hospital vital signs revealed respiratory rate of 25.  Remainder of vitals within normal limits.  Originally on room air-oxygen saturations in the upper 80s.  Vital signs significant for 0 white blood cell count of 12, neutrophils 74.  Metabolic panel significant for a blood glucose of 102 12. During ambulation c the ED physician patient had tachycardia and dyspnea on exertion.  Patient is being brought in for further workup and management.  Please note: Patient received first dose Pfizer vaccine on 2/15/21/2021 Lot # EL9265 and the second dose on 3/10/2021 Lot # EN6206 and booster on 10/1/21 Lot # FF2588
This spontaneous report as received from a consumer (compliance specialist) refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 08-FEB-2018, the patient was vaccinated with a properly stored expired dose of PROQUAD (lot # M035690, Expiry date : 06-FEB-2018) for prophylaxis (expired product administered). Other suspect therapies included sterile diluent (STERILE DILUENT).  No adverse effects were reported. There was no product quality complaint involved.
RIGHT ARM SWELLING AT SITE OF INJECTION AND DOWN TO ELBOW.  PER PATIENT, FEELS TIGHT AND IS SOMEWHAT RED.  RECOMMENDED THAT PATIENT APPLY ICE 10MIN ON AND 10MIN OFF.  ELEVATE ALSO.  IF SWELLING CONTINUES CONTACT PHYSICIAN.
Post vax, the patient developed full blown chickenpox with 250-500 lesions. Additional patients had a similar experience following exposure to varicella virus vaccine live and the above mentioned patient. No further information is available.
Developed genital warts for 2 weeks.  Rx: Aldara 5% cream 3 times a week for 6 weeks.  Dermatologic.
Developed "Moderna Arm" (e.g. large red splotch at injection site) 8 days after the first dose of the vaccine and 1-2 days after the second dose of the vaccine.  Recovered from first instance.  Second instance is still present but the shot was only 3 days ago.
sick; Initial information received on 08-Oct-2020 regarding an unsolicited valid non-serious case received from a social media consumer.  This case involves patient (unknown demographics) who experienced sick (illness), while he/she received vaccine INFLUENZA VACCINE.  Medical history, medical treatment, concomitant medication, vaccination and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious sick (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event was not reported.  There will be no information available on the batch number for this case.
When usually side effect start; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (When usually side effect start) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (When usually side effect start). At the time of the report, VACCINATION COMPLICATION (When usually side effect start) outcome was unknown.            No concomitant and treatment products reported. Action taken with mRNA-1273 in response to the events was Not Applicable.
Second does on 4/6/21, day 16 of my 28-day menstrual cycle, when estrogen and progesterone were relatively low. Flu-like side effects started about 12 hours after second dose and lasted about 24 hours. Fully recovered and felt good  4/8 - 12. What was unusual is that on the evening of 4/12/21, I developed moderate flu-like side effects again, as bad or perhaps worse than first occurrence, lasting through 4/14/21. 4/12 was day 22 of my menstrual cycle and coincides with an increase in progesterone and estrogen. Moderate symptoms included persistent fever (high of 102.3 while on OTC fever relief), visibly swollen lymphnodes (turkey neck), sore throat, joint aches, muscle aches. Mild symptoms included nausea and abdominal pain.   Treatment with OTC acetaminophen (not that effective) and ibuprofen (more effective).
This spontaneous report as received from a physician via company representative refers to an unspecified number of non pregnant female patients of unknown age (reported also as girls). On an unknown date, the patients were vaccinated with GARDASIL (injection, dose, lot # and expiration date not reported). On an unknown date, the patients had Pap smears (papniculaou smears) and Colposcopies (also reported as treatment) performed with abnormal results. The patient had HPV (Human Papilloma Virus ) DNA (deoxyribonucleic acid) capture tewsts performed with no results provided (date unspecified). There was also reported that colposcopy was intervention to prevent serious criteria. The patients sought medical attention by office visit (date unspecified). The outcome of the events was not reported. The relatedness between the events and GARDASIL was not reported. Additional information is not expected.
The vaccine caused my to experience the following : headache, tiredness, weakness, runny nose,  pained swelling in my arm,  and vomiting, which I am still experiencing today.
This spontaneous report refers to a patient of unknown age and gender. The patient's medical history was not reported. On 29-DEC-2017, the patient was vaccinated with an improperly stored dose of VARIVAX lot # N014632, expiration date 11-MAY-2019 for prophylaxis (dose, route and site of administration were not reported). The vaccine underwent a temperature excursion of -9 to 8 degrees Celsius for 4 hours and 25 minutes. Other temperature excursions included -14 to -10 degrees Celsius for 1 hour and 15 minutes and -2.8 degrees Celsius for 1 hour and 41 minutes. Digital data logger was involved. No adverse effects were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1802USA002592, US-009507513-1802USA001673.
Very swollen and very hard and painful upper arm from shoulder to elbow and around inner side of arm, very red, very hot,  also itchy, plus swollen and painful lymph glands in armpit. Initially slightly sore and hard at injection site, but by 1/14/21 armpit pain and increased swelling, hardness, redness, heat. Itching then began. Increasingly uncomfortable through 1/17/21.  All symptoms appear to be resolving some as of Monday1/18/21, but redness and itching continued to move around inside of arm.
runny nose after getting the vaccine; This is a spontaneous report from a contactable consumer. An adult male patient, of an unspecified age, received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date (at an unspecified age) as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. It was unknown if the patient received any other vaccines within 4 weeks prior to the vaccination. It was unknown if prior to vaccination, the patient was diagnosed with COVID-19. On an unspecified date, the patient had a runny nose after getting the vaccine. Since the vaccination, it was unknown if the patient had been tested for COVID-19. The clinical outcome of the runny nose after getting the vaccine was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt recvd 2nd dose of vax & devel welts & itching localized @ the arm where vax was given; MD felt was allergic reaction;
Cold sores on her mouth and around her mouth started popping up; she got sick like sick sick; sore; This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (Cold sores on her mouth and around her mouth started popping up), ILLNESS (she got sick like sick sick) and PAIN (sore) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051F21A, 027L20A and 011M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Jan-2022, the patient experienced ILLNESS (she got sick like sick sick) and PAIN (sore). On 14-Jan-2022, the patient experienced ORAL HERPES (Cold sores on her mouth and around her mouth started popping up). At the time of the report, ORAL HERPES (Cold sores on her mouth and around her mouth started popping up), ILLNESS (she got sick like sick sick) and PAIN (sore) outcome was unknown.            No concomitant medications were reported.  No treatment information was reported.
I got all four doses of the vaccine. The initial two ad then two boosters. Why do I have COVID-19 again? The vaccine doesn't work.; I got all four doses of the vaccine. The initial two ad then two boosters. Why do I have COVID-19 again? The vaccine doesn't work.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 73-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "I got all four doses of the vaccine. The initial two ad then two boosters. Why do I have COVID-19 again? The vaccine doesn't work.".  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.
Pt received Pfizer x2.  Pt tested COVID + on 8/26/21 and admitted to hospital for COVID on 8/26/2021. Pt received remdesivir x4 doses and dexamethasone.
This case was reported by a physician and described the occurrence of crying in a 6 month old female patient who received DTaP adsorbed, hepatitis B recombinant and inactivated poliovirus vaccine combined (Pediarix). On an unspecified date, at the age of four months, the patient received the second dose of Pediarix. On the same date, the patient concurrently received haemophilus influenza type b conjugate vaccine. "That same night, " the patient experienced crying which lasted for three to four hours, then resolved. ON an unspecified date approximately two months later, at the age of 6 months, the patient received the third dose of Pediarix. "That same night," the patient again experienced crying which lasted for three to four hours, then resolved. The physician considered the event was possibly related to vaccination with Pediarix. Follow-up - No further information available to date.